Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate the safety, tolerability, pharmacodynamics and
pharmacokinetics of AZD1722 in healthy Japanese subjects at increasing doses given for 7 days
in order to allow for including Japanese subjects in future global studies. A cohort of
Caucasian subjects will be included in the study to evaluate cardiac effects, assessed by
digital ECGs (dECG) recordings, also in Caucasian subjects.